LAVA Therapeutics NV financial data

Symbol
LVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, Utrecht, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
LAVA Therapeutics BV (to 3/24/2021)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.3M shares
Common Stock, Shares, Outstanding 26.3M shares +0.06%
Entity Public Float 29M USD
Common Stock, Value, Issued 3.72M USD +0.05%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35M USD -20.8%
Other Assets, Current 1.65M USD -2.94%
Assets, Current 79.3M USD -19.8%
Property, Plant and Equipment, Net 1M USD -37.5%
Operating Lease, Right-of-Use Asset 441K USD -48.4%
Other Assets, Noncurrent 91K USD -71.5%
Assets 80.8M USD -20.5%
Accounts Payable, Current 2.72M USD -38.8%
Employee-related Liabilities, Current 1.4M USD -5.22%
Liabilities, Current 18M USD +20.9%
Contract with Customer, Liability, Noncurrent 35M USD 0%
Operating Lease, Liability, Noncurrent 80K USD -80.7%
Liabilities 53.1M USD +5.52%
Accumulated Other Comprehensive Income (Loss), Net of Tax -12.7M USD -16.1%
Retained Earnings (Accumulated Deficit) -175M USD -16.8%
Stockholders' Equity Attributable to Parent 27.7M USD -46%
Liabilities and Equity 80.8M USD -20.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 90M shares +100%
Common Stock, Shares, Issued 26.3M shares +0.06%
Common Stock, Par or Stated Value Per Share 0.14 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35M USD -20.8%
Deferred Tax Assets, Valuation Allowance 41.4M USD +11.7%
Deferred Tax Assets, Gross 41.5M USD +11.4%
Operating Lease, Liability 395K USD
Lessee, Operating Lease, Liability, to be Paid 425K USD
Property, Plant and Equipment, Gross 3.01M USD -9.86%
Operating Lease, Liability, Current 315K USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 77K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 343K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.16 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 3K USD
Deferred Tax Assets, Operating Loss Carryforwards 28M USD +51.7%
Preferred Stock, Shares Authorized 45M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2K USD
Additional Paid in Capital 212M USD +1.56%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 138K USD -37.3%